HuMiX, the personalised Human Microbial Cross-talk model, is an in-vitro platform which represents actual conditions and processes that occur within our intestines. With HuMiX, we can analyse the complex interactions between bacteria human cells and immune responses, to identify the action of probiotics and drugs and validate their mode of action on health or disease onset. We are raising seed and series A funding to implement the screening platform and initiate our discovery pipeline building on validation in oncology and immunology.
Currently leading the HuMiX microbiome start-up initiative, I have pioneered HTS, LIMS, and imaging based genotype screening at J&J Janssen research. Developed and commercialised High Content Imaging devices as CTO at Digilab / Maia Scientific. Managed a global sales network at Trinean for genomic and proteomic QC equipment. And contributed to new laboratory platforms including development and implementation of a fully automated pathogen virology lab.
After six succesful editions, Innovation for Health will be organised for the seventh year in a row on Thursday 13 February 2020!
We will open registration for this new edition in May 2019. From that moment on you can benefit from attractive early-bird rates. When you are interested in participation as e.g. sponsor, exhibitor or speaker, you can contact us directly via phone or e-mail.
The aftermovie of Innovation for Health 2019 is online now, including highlights of the programme and exhibition.
Watch the aftermovie and experience Innovation for Health 2019 in only 2 minutes!
Looking forward welcoming you to the next edition of Innovation for Health in 2020! (date will be announced soon)
Watch the aftermovie
Did you enjoy Innovation for Health & Global Investor Forum 2019?
Take a look at our photo impression and you will experience the event of 14 February all over again!
Go to Photo Impression
© 2019 Innovation for Health